Fields »
ABOUT
HELP
BLOG

575 GENES FOUND

Show / hide columns

XML | RDF | TSV | Page of 12 | next »

Gene

 

 

Gene description

x

 

 

 

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

IH abundance (Normal Tissue)

x

RNA abundance (Normal Tissue)

x

Subcellular location

x

Prognostic p-value

x

 

RNA tissue category

x

RNA TS

x

RNA TS TPM

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 
LRP11Low density lipoprotein receptor-related protein 11
MitochondriaBreast cancer: 2.31e-8
Liver cancer: 2.01e-5
Expressed in all
ZNF385BZinc finger protein 385B
Nucleoli fibrillar centerRenal cancer: 1.04e-9
Breast cancer: 4.86e-8
Tissue enhancedlung:27.4
PGK1Phosphoglycerate kinase 1
Breast cancer: 7.05e-8
Head and neck cancer: 2.65e-6
Cervical cancer: 2.69e-5
Liver cancer: 2.74e-4
Pancreatic cancer: 8.34e-4
Expressed in all
PCMT1Protein-L-isoaspartate (D-aspartate) O-methyltransferase
CytosolBreast cancer: 4.02e-7
Head and neck cancer: 1.88e-4
Liver cancer: 2.58e-4
Endometrial cancer: 4.27e-4
Urothelial cancer: 6.38e-4
Cervical cancer: 9.58e-4
Expressed in all
TFPI2Tissue factor pathway inhibitor 2
Breast cancer: 8.33e-7
Endometrial cancer: 5.42e-4
Renal cancer: 8.53e-4
Tissue enriched23placenta:1205.5
FAM173BFamily with sequence similarity 173, member B
Nucleus
Vesicles		Breast cancer: 1.32e-6
Expressed in all
IL27RAInterleukin 27 receptor, alpha
Vesicles
Cytosol		Renal cancer: 2.58e-10
Breast cancer: 1.74e-6
Mixed
JCHAINJoining chain of multimeric IgA and IgM
Head and neck cancer: 7.56e-7
Breast cancer: 1.81e-6
Renal cancer: 1.40e-4
Expressed in all
ARID5AAT rich interactive domain 5A (MRF1-like)
Nucleus
Nucleoli		Renal cancer: 4.24e-8
Breast cancer: 2.05e-6
Expressed in all
MAP2K6Mitogen-activated protein kinase kinase 6
Nucleus
Cytosol		Breast cancer: 2.27e-6
Pancreatic cancer: 7.52e-4
Mixed
NEFHNeurofilament, heavy polypeptide
Nucleus
Nuclear bodies
Centrosome		Breast cancer: 2.33e-6
Tissue enriched13prostate:484.2
DEF6DEF6 guanine nucleotide exchange factor
NucleoplasmRenal cancer: 1.02e-8
Breast cancer: 3.02e-6
Cervical cancer: 1.08e-4
Colorectal cancer: 1.71e-4
Endometrial cancer: 2.37e-4
Mixed
C6orf141Chromosome 6 open reading frame 141N/A
Nuclear membraneBreast cancer: 3.92e-6
Endometrial cancer: 1.15e-4
Tissue enhancedgallbladder:9.3
CA3Carbonic anhydrase III
Breast cancer: 4.24e-6
Tissue enriched16skeletal muscle:1839.1
GSTK1Glutathione S-transferase kappa 1
PeroxisomesRenal cancer: 2.10e-6
Breast cancer: 4.41e-6
Expressed in all
PEX10Peroxisomal biogenesis factor 10
NucleoplasmRenal cancer: 4.16e-6
Breast cancer: 4.50e-6
Expressed in all
MAL2Mal, T-cell differentiation protein 2 (gene/pseudogene)
Breast cancer: 4.57e-6
Renal cancer: 2.39e-5
Endometrial cancer: 8.44e-5
Pancreatic cancer: 3.98e-4
Mixed
SGK3Serum/glucocorticoid regulated kinase family, member 3
Breast cancer: 5.52e-6
Cervical cancer: 8.28e-4
Pancreatic cancer: 9.65e-4
Expressed in all
LIMCH1LIM and calponin homology domains 1
Actin filamentsRenal cancer: 3.82e-7
Breast cancer: 5.55e-6
Mixed
ATP5BATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide
MitochondriaRenal cancer: 1.43e-9
Breast cancer: 7.17e-6
Expressed in all
SLC5A8Solute carrier family 5 (sodium/monocarboxylate cotransporter), member 8
Breast cancer: 9.04e-6
Renal cancer: 1.97e-4
Tissue enhancedcervix, uterine:16.2
thyroid gland:14.8
RTN4IP1Reticulon 4 interacting protein 1
Renal cancer: 8.55e-6
Breast cancer: 9.18e-6
Mixed
RAC2Ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
Renal cancer: 1.06e-6
Breast cancer: 1.03e-5
Expressed in all
TPD52Tumor protein D52
Golgi apparatus
Cytosol		Renal cancer: 4.77e-6
Breast cancer: 1.11e-5
Expressed in all
SPDYCSpeedy/RINGO cell cycle regulator family member C
Breast cancer: 1.20e-5
Tissue enhancedliver:1.4
testis:1.5
PIGRPolymeric immunoglobulin receptor
Nucleus
Nucleoli
Cytosol		Breast cancer: 1.22e-5
Renal cancer: 5.08e-5
Endometrial cancer: 2.57e-4
Tissue enhancedcolon:1721.7
duodenum:2732.8
ZMYM6Zinc finger, MYM-type 6
NucleoplasmBreast cancer: 1.30e-5
Mixed
NFKBIANuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
CytosolBreast cancer: 1.33e-5
Expressed in all
PDSS2Prenyl (decaprenyl) diphosphate synthase, subunit 2
CytosolRenal cancer: 3.75e-7
Breast cancer: 1.34e-5
Colorectal cancer: 5.74e-5
Expressed in all
TNFRSF17Tumor necrosis factor receptor superfamily, member 17
Head and neck cancer: 1.58e-6
Breast cancer: 1.35e-5
Tissue enhancedtonsil:38.2
RARRES3Retinoic acid receptor responder (tazarotene induced) 3
Pancreatic cancer: 6.26e-6
Breast cancer: 1.35e-5
Cervical cancer: 4.00e-4
Expressed in all
ATG4AAutophagy related 4A, cysteine peptidase
Actin filaments
Microtubules		Breast cancer: 1.36e-5
Expressed in all
TRMT2BTRNA methyltransferase 2 homolog B
Nucleoplasm
Nuclear bodies		Renal cancer: 2.30e-7
Breast cancer: 1.58e-5
Expressed in all
SERPINA1Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
VesiclesBreast cancer: 1.61e-5
Colorectal cancer: 5.86e-4
Tissue enriched19liver:15340.0
DCTPP1DCTP pyrophosphatase 1
Nucleoplasm
Cytosol		Renal cancer: 9.71e-9
Breast cancer: 1.64e-5
Liver cancer: 6.28e-4
Expressed in all
NFKBIENuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon
Nucleus
Nucleoli fibrillar center
Cytosol		Renal cancer: 1.37e-6
Breast cancer: 1.72e-5
Liver cancer: 3.50e-4
Urothelial cancer: 8.07e-4
Mixed
TRAPPC12Trafficking protein particle complex 12
Breast cancer: 1.80e-5
Renal cancer: 2.44e-4
Pancreatic cancer: 9.15e-4
Expressed in all
XRCC4X-ray repair complementing defective repair in Chinese hamster cells 4
NucleusBreast cancer: 1.80e-5
Mixed
CD52CD52 molecule
Breast cancer: 1.85e-5
Endometrial cancer: 2.06e-4
Head and neck cancer: 4.45e-4
Renal cancer: 5.85e-4
Tissue enriched34epididymis:43067.6
RASGEF1ARasGEF domain family, member 1A
Golgi apparatusRenal cancer: 4.11e-7
Breast cancer: 1.86e-5
Endometrial cancer: 4.28e-4
Tissue enhancedcerebral cortex:22.7
C6orf226Chromosome 6 open reading frame 226
Nuclear specklesBreast cancer: 1.93e-5
Renal cancer: 3.35e-4
Pancreatic cancer: 5.13e-4
Expressed in all
TIMM17ATranslocase of inner mitochondrial membrane 17 homolog A (yeast)
Nucleoplasm
Mitochondria		Breast cancer: 1.98e-5
Expressed in all
TIPARPTCDD-inducible poly(ADP-ribose) polymerase
Nucleoplasm
Microtubules
Microtubule organizing center		Breast cancer: 2.00e-5
Expressed in all
TAGLN2Transgelin 2
Actin filaments
Cytosol		Renal cancer: 1.92e-10
Breast cancer: 2.06e-5
Liver cancer: 7.07e-5
Expressed in all
PTGES3Prostaglandin E synthase 3 (cytosolic)
Nucleoplasm
Cytosol		Liver cancer: 4.44e-6
Breast cancer: 2.15e-5
Ovarian cancer: 4.36e-4
Expressed in all
RAB5BRAB5B, member RAS oncogene family
VesiclesBreast cancer: 2.24e-5
Expressed in all
CEBPDCCAAT/enhancer binding protein (C/EBP), delta
NucleoplasmRenal cancer: 2.87e-7
Breast cancer: 2.28e-5
Expressed in all
FAM127CFamily with sequence similarity 127, member C
Breast cancer: 2.41e-5
Stomach cancer: 3.72e-4
Mixed
CD24CD24 molecule
VesiclesBreast cancer: 2.44e-5
Colorectal cancer: 3.29e-4
Liver cancer: 7.58e-4
Tissue enhancedthyroid gland:2692.6
BEND5BEN domain containing 5N/A
Nuclear speckles
Cytosol		Urothelial cancer: 8.30e-6
Breast cancer: 2.50e-5
Pancreatic cancer: 1.29e-4
Lung cancer: 1.29e-4
Mixed

Page of 12 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.